Cerebral venous thrombosis in clinical practice

Pizova N.V.; Pizov A.V.

doi:https://doi.org/10.17116/jnevro202512508211

Рекомендуем статьи по данной теме:

Особенности первичных и повторных ишемических инсультов у мужчин в возрасте 18—50 лет. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2024;(12-2):65-74

Неразрешенная проблема: химиоиндуцированная полинейропатия. Онкология. Журнал им. П.А. Герцена. 2024;(5):76-81

Факторы риска, ассоциированные с миопической макулопатией при приобретенной миопии. Вестник офтальмологии. 2024;(5):35-45

Обоснование применения нелинейных статистических методов при анализе связей факторов риска с фатальными событиями по данным длительного проспективного наблюдения в популяциях России и Соединенных Штатов Америки. Профилактическая медицина. 2024;(11):34-39

Особенности коморбидной патологии у лиц молодого возраста. Профилактическая медицина. 2024;(11):63-69

Сравнение моделей прогнозирования спонтанных преждевременных родов. Медицинские технологии. Оценка и выбор. 2024;(4):10-19

Структурно-функциональные особенности магистральных артерий головного мозга и фактор некроза опухоли-альфа у пациентов с хроническими неинфекционными заболеваниями. Журнал неврологии и психиатрии им. С.С. Корсакова. 2024;(11):178-184

Рак желудка: заболеваемость, факторы риска, скрининг. Профилактическая медицина. 2024;(12):135-139

Информативность разных методов диагностического обследования при инвертированной папилломе полости носа и околоносовых пазух. Российская ринология. 2024;(4):269-274

Вклад Сергея Селивановича Головина в развитие офтальмологии. Вестник офтальмологии. 2024;(6):159-163

Резюме / Abstract:

Тромбоз церебральных вен составляет от 0,5 до 3% всех инсультов. Церебральный венозный тромбоз несколько чаще встречается у молодых людей. Клиническая картина тромбоза церебральных вен разнообразна (например, головные боли, судороги) и постановка этого диагноза требует высокого уровня знаний. В целом, пациенты с тромбозом церебральных вен имеют благоприятный исход. Предрасполагающие факторы к церебральному венозному тромбозу выявляются у большинства пациентов с этим заболеванием и могут быть преходящими или хроническими. В обзоре обобщены современные знания о факторах риска, лечении и исходах у взрослых. Предложен алгоритм ведения пациентов с тромбозом церебральных вен.

Ключевые слова / Keywords:

церебральный венозный тромбоз

факторы риска

клиника

алгоритм ведения

Авторы / Authors:

Пизова Н.В.

ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России

ORCID: 0000-0002-7465-0677

Пизов А.В.

ФГБОУ ВО «Ярославский государственный педагогический университет им. К.Д. Ушинского»

ORCID: 0000-0002-0522-675X

Дата поступления:

21.04.2025

Дата принятия в печать:

30.04.2025

Закрыть метаданные

Литература / References:

Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158-1192. https://doi.org/10.1161/STR.0b013e31820a8364
Moraes Junior AAA, Conforto AB. Cerebral venous thrombosis. Arq Neuropsiquiatr. 2022;80(5 Suppl 1):53-59. https://doi.org/10.1590/0004-282X-ANP-2022-S108
Alet M, Ciardi C, Alemán A, et al. Argentinian Stroke and Cerebrovascular Diseases Study Group — Argentine Neurological Society. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and literature review. J Stroke Cerebrovasc Dis. 2020;29:105145. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105145
Devasagayam S, Wyatt B, Leyden J, et al. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47:2180-2182. https://doi.org/10.1161/STROKEAHA.116.013617
Kristoffersen ES, Harper CE, Vetvik KG, et al. Incidence and mortality of cerebral venous thrombosis in a Norwegian population. Stroke. 2020;51:3023-3029. https://doi.org/10.1161/STROKEAHA.120.030800
Ruuskanen JO, Kytö V, Posti JP, et al. Cerebral venous thrombosis: Finnish nationwide trends. Stroke. 2021;52:335-338. https://doi.org/10.1161/STROKEAHA.120.031026
Otite FO, Patel S, Sharma R, et al. Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States. Neurology. 2020;95(16):e2200-e2213. https://doi.org/10.1212/WNL.0000000000010598
Ken-Dror G, Cotlarciuc I, Martinelli I, et al. Genome-wide association study identifies first locus associated with susceptibility to cerebral venous thrombosis. Ann Neurol. 2021;90(5):777-788. https://doi.org/10.1002/ana.26205
Idiculla PS, Gurala D, Palanisamy M, et al. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369-379. https://doi.org/10.1159/000509802
Ranjan R, Ken-Dror G, Sharma P. Pathophysiology, diagnosis and management of cerebral venous thrombosis: A comprehensive review. Medicine (Baltimore). 2023;102(48):e36366. https://doi.org/10.1097/MD.0000000000036366
Ferro JM, Canhao P, Stam J, et al; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670. https://doi.org/10.1161/01.STR.0000117571.76197.26
Duman T, Uluduz D, Midi I, et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis. 2017;26:1848-1857. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.04.020
Ferro JM, Bousser MG, Canhão P, et al; European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis. Eur J Neurol. 2017;24:1203-1213. https://doi.org/10.1111/ene.13381
Pai N, Ghosh K, Shetty S. Hereditary thrombophilia in cerebral venous thrombosis: a study from India. Blood Coagul Fibrinolysis. 2013;24:540-543. https://doi.org/10.1097/MBC.0b013e32835fad1e
Kumar R, Vinny PW, Nair VG, et al. Comprehensive Thrombophilia Evaluation in Cerebral Venous Thrombosis: A Single Center Cross Sectional Study. Indian J Hematol Blood Transfus. 2022;38(3):522-528. https://doi.org/10.1007/s12288-021-01480-3
Pérez Lázaro C, López-Bravo A, Gómez-Escalonilla Escobar C, et al. Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study. Neurologia (Engl Ed). 2021:S0213-4853(21)00116-X. https://doi.org/10.1016/j.nrl.2021.05.016
Sassi SB, Touati N, Baccouche H, et al. Cerebral Venous Thrombosis: A Tunisian Monocenter Study on 160 Patients. Clin Appl Thromb Hemost. 2017;23(8):1005-1009. https://doi.org/10.1177/1076029616665168
Bajko Z, Motataianu A, Stoian A, et al. Gender Differences in Risk Factor Profile and Clinical Characteristics in 89 Consecutive Cases of Cerebral Venous Thrombosis. J Clin Med. 2021;10(7):1382. https://doi.org/10.3390/jcm10071382
Triquenot Bagan A, Crassard I, Drouet L, et al. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)-Comparison With ISCVT Cohort. Front Neurol. 2021;12:753110. https://doi.org/10.3389/fneur.2021.753110
Khan M, Arauz A, Uluduz D, et al; VENOST Study Group. Predictors of mortality and functional outcome in pregnancy and puerperium-related cerebral venous thrombosis. Cerebrovasc Dis. 2023;52:393-400. https://doi.org/10.1159/000527155
Kashkoush AI, Ma H, Agarwal N, et al. Cerebral venous sinus thrombosis in pregnancy and puerperium: a pooled, systematic review. J Clin Neurosci. 2017;39:9-15. https://doi.org/10.1016/j.jocn.2017.02.046
Khealani BA, Mapari UU, Sikandar R. Obstetric cerebral venous thrombosis. J Pak Med Assoc. 2006;56:490-3. https://pubmed.ncbi.nlm.nih.gov/17183973
Swartz RH, Cayley ML, Foley N, et al. The incidence of pregnancy-related stroke: a systematic review and meta-analysis. Int J Stroke. 2017;12:687-697. https://doi.org/10.1177/1747493017723271
Roeder HJ, Lopez JR, Miller EC. Ischemic stroke and cerebral venous sinus thrombosis in pregnancy. Handb Clin Neurol. 2020;172:3-31. https://doi.org/10.1016/B978-0-444-64240-0.00001-5
Tanislav C, Siekmann R, Sieweke N, et al. Cerebral vein thrombosis: Clinical manifestation and diagnosis. BMC Neurol. 2011;11:69. https://doi.org/10.1186/1471-2377-11-69
Algahtani H, Bazaid A, Shirah B, et al. Cerebral venous sinus thrombosis in pregnancy and puerperium: A comprehensive review. Brain Circ. 2022;8(4):180-187. https://doi.org/10.4103/bc.bc_50_22
Goualou M, Noumegni S, de Moreuil C, et al. Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis. Thromb Haemost. 2023;123(3):283-294. https://doi.org/10.1055/s-0042-1760255
Akinshina S, Bitsadze V, Khizroeva J, et al. Cerebral vein thrombosis: management tactics with a focus on pregnancy, the use of hormone therapy and assisted reproductive technologies. J Matern Fetal Neonatal Med. 2025;38(1):2447349. https://doi.org/10.1080/14767058.2024.2447349
Aguiar de Sousa D, Canhão P, Ferro JM. Safety of pregnancy after cerebral venous thrombosis: systematic review update. J Neurol. 2018;265(1):211-212. https://doi.org/10.1007/s00415-017-8666-x
Getahun D, Nash R, Flanders WD, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169:205-213. https://doi.org/10.7326/m17-2785
Amoozegar F, Ronksley PE, Sauve R, Menon BK. Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis. Front Neurol. 2015;6:7. https://doi.org/10.3389/fneur.2015.00007
Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, et al. Estrogens, progestogens and thrombosis. J Thromb Haemost. 2003;1:1371-1380. https://doi.org/10.1046/j.1538-7836.2003.00264.x
Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013;347:0. https://doi.org/10.1136/bmj.f5298
Максимова М.Ю., Дубовицкая Ю.И., Шувахина Н.А. Клиника, диагностика и лечение тромбоза мозговых вен и венозных синусов. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2018;118(3-2):3-8. https://doi.org/10.17116/jnevro2018118323-8
Krumb E, Lefebvre C, Peeters A, Hermans C. Cerebral venous thrombosis revealing Behcet’s disease in a Moroccan patient: a case report and literature review. SAGE Open Med Case Rep. 2018:6:2050313X18767053. https://doi.org/10.1177/2050313X18767053
Shi J, Huang X, Li G, et al. Cerebral venous sinus thrombosis in Behcet’s disease: a retrospective case‐control study. Clin Rheumatol. 2018;37(1):51-57. https://doi.org/10.1007/s10067-017-3718-2
Wasay M, Bakshi R, Bobustuc G, et al. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis. 2008;17(2):49‐54. https://doi.org/10.1016/j.jstrokecerebrovasdis.2007.10.001
Yesilot N, Bahar S, Yilmazer S, et al. Cerebral venous thrombosis in Behcet’s disease compared to those associated with other etiologies. J Neurol. 2009;256(7):1134‐1142. https://doi.org/10.1007/s00415-009-5088-4
Sorgun MH, Rzayev S, Kural MA, et al. Cerebral venous thrombosis in Behcet’s disease patients compared to other causes of cerebral venous thrombosis: a retrospective study. Arch Rheumatol. 2016;31(3):248‐253. https://doi.org/10.5606/ArchRheumatol.2016.5749
Wang L, Chen H, Zhang Y, et al. Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single‐Centre experience in China. J Immunol Res. 2015;2015:540738. https://doi.org/10.1155/2015/540738
Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15(3):137‐152. https://doi.org/10.1038/s41584-018-0156-8
Jerez‐Lienas A, Mathian A, Aboab J, et al. Cerebral vein thrombosis in the antiphospholipid syndrome: analysis of a series of 27 patients and review of the literature. Brain Sci. 2021;11(12):1641. https://doi.org/10.3390/brainsci11121641
Zhang B, Lang Y, Zhang W, et al. Characteristics and management of autoimmune disease‐associated cerebral venous sinus thrombosis. Front Immunol. 2021;12:671101. https://doi.org/10.3389/fimmu.2021.671101
DeFilippis EM, Barfield E, Leifer D, et al. Cerebral venous thrombosis in inflammatory bowel disease. J Dig Dis. 2015;16(2):104‐108. https://doi.org/10.1111/1751-2980.12212
Cohen JB, Comer DM, Yabes JG, et al. Inflammatory bowel disease and thrombosis: a national inpatient sample study. TH Open. 2020;4:0-8. https://doi.org/10.1055/s-0040-1710506
Katsanos AH, Katsanos KH, Kosmidou M, et al. Cerebral sinus venous thrombosis in inflammatory bowel diseases. QJM. 2013;106(5):401‐413. https://doi.org/10.1093/qjmed/hcs229
Zhou Y, Jiang H, Wei H, et al. Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers. CNS Neurosci Ther. 2023;29(10):2760-2774. https://doi.org/10.1111/cns.14321
Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007;102:174-186. https://doi.org/10.1111/j.1572-0241.2006.00943.x
Taous A, Berri MA, Lamsiah T, et al. Cerebral venous thrombosis revealing an ulcerative colitis. Pan Afr Med J. 2016;23:120. https://doi.org/10.11604/pamj.2016.23.120.9186
de Lacerda JF, Oliveira SN, Ferro JM. Chronic myeloproliferative diseases. Handb Clin Neurol. 2014;120:1073‐1081. https://doi.org/10.1016/B978-0-7020-4087-0.00072-3
Miranda B, Ferro JM, Canhao P, et al; ISCVT Investigators. Venous thromboembolic events after cerebral vein thrombosis. Stroke. 2010;41(9):1901‐1906. https://doi.org/10.1161/STROKEAHA.110.581223
Martinelli I, De Stefano V, Carobbio A, et al. Cerebral vein thrombosis in patients with Philadelphia‐negative myeloproliferative neoplasms. An European Leukemia Net study. Am J Hematol. 2014;89(11):E200‐E205. https://doi.org/10.1002/ajh.23809
Dentali F, Ageno W, Rumi E, et al. Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases. Thromb Res. 2014;134(1):41‐43. https://doi.org/10.1016/j.thromres.2014.03.040
Gangat N, Guglielmelli P, Betti S, et al. Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases. Am J Hematol. 2021;96(12):1580-1586. https://doi.org/10.1002/ajh.26336
King A, Doyle KM. Implications of COVID-19 to stroke medicine: an epidemiological and pathophysiological perspective. Curr Vasc Pharmacol. 2022;20:333-340. https://doi.org/10.2174/1570161120666220428101337
Simonetto M, Wechsler PM, Merkler AE. Stroke treatment in the era of COVID-19: a review. Curr Treat Options Neurol. 2022;24:155-171. https://doi.org/10.1007/s11940-022-00713-8
Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126(Pt 5):1015-25. https://doi.org/10.1093/brain/awg113
Deliran SS, Brouwer MC, Coutinho JM, et al. Bacterial meningitis complicated by cerebral venous thrombosis. Eur Stroke J. 2020 Dec;5(4):394-401. https://doi.org/10.1177/2396987320971112
Shabo E, Wach J, Hamed M, et al. Asymptomatic postoperative cerebral venous sinus thrombosis after posterior fossa tumor surgery: incidence, risk factors, and therapeutic options. Neurosurgery. 2023;92:1171-1176. https://doi.org/10.1227/neu.0000000000002340
Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3478-3490. https://doi.org/10.1111/ene.14727
Abdalkader M, Shaikh SP, Siegler JE, et al. Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J Stroke Cerebrovasc Dis. 2021;105733. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105733
Zhang S, Zhao H, Li H, et al. Decompressive craniectomy in hemorrhagic cerebral venous thrombosis: clinicoradiological features and risk factors. J Neurosurg. 2016;127(4):709-715. https://doi.org/10.3171/2016.8.JNS161112
Ferro JM, Canhão P, Bousser M-G, et al. ISCVT Investigators Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927-1932. https://doi.org/10.1161/01.STR.0000177894.05495.54
Lindgren E, Silvis SM, Hiltunen S, et al. Acute symptomatic seizures in cerebral venous thrombosis. Neurology. 2020;95:e1706-e1715. https://doi.org/10.1212/WNL.0000000000010577
Saposnik G, Bushnell C, Coutinho JM, et al; American Heart Association Stroke Council; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovasc ular and Stroke Nursing; and Council on Hypertension. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association. Stroke. 2024;55(3):e77-e90. https://doi.org/10.1161/STR.0000000000000456
Xu W, Gao L, Li T, et al. The performance of CT versus MRI in the differential diagnosis of cerebral venous thrombosis. Thromb Haemost. 2018;118:1067-1077. https://doi.org/10.1055/s-0038-1642636
Klein P, Shu L, Nguyen TN, et al; ACTION-CVT Study Group 1. Outcome prediction in cerebral venous thrombosis: the IN-REvASC Score. J Stroke. 2022;24:404-416. https://doi.org/10.5853/jos.2022.01606
Hiltunen S, Putaala J, Haapaniemi E, et al. Long-term outcome after cerebral venous thrombosis: analysis of functional and vocational outcome, residual symptoms, and adverse events in 161 patients. J Neurol. 2016;263:477-484. https://doi.org/10.1007/s00415-015-7996-9
Koopman K, Uyttenboogaart M, Vroomen PC, et al. Long-term sequelae after cerebral venous thrombosis in functionally independent patients. J Stroke Cerebrovasc Dis. 2009;18:198-202. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.10.004
Preter M, Tzourio C, Ameri A, et al. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke. 1996;27:243-246. https://doi.org/10.1161/01.str.27.2.243
Field T, Dizonno V, Almekhlafi MA, et al; SECRET Investigators; SECRET Investigators. Study of Rivaroxaban in Cerebral Venous Thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis. Stroke. 2023;54:2724-2736. https://doi.org/10.1161/STROKEAHA.123.044113
Liu L, Jiang H, Wei H, et al. Risk factors of impaired employability after cerebral venous thrombosis. CNS Neurosci Ther. 2023;29:1086-1093. https://doi.org/10.1111/cns.14083
Gasparini S, Neri S, Brigo F, et al. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. Neurol Sci. 2022;43:5229-5236. https://doi.org/10.1007/s10072-022-06148-y
Sanchez van Kammen M, Lindgren E, et al. Late seizures in cerebral venous thrombosis. Neurology. 2020;95:e1716-e1723. https://doi.org/10.1212/WNL.0000000000010576
Martinelli I, Bucciarelli P, Passamonti SM, et al. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation. 2010;121:2740-2746. https://doi.org/10.1161/CIRCULATIONAHA.109.927046
Palazzo P, Agius P, Ingrand P, et al. Venous thrombotic recurrence after cerebral venous thrombosis: a long-term follow-up study. Stroke. 2017;48:321-326. https://doi.org/10.1161/strokeaha.116.015294
Ferro JM, Bousser MG, Canhão P, et al; European Stroke Organization. European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis — endorsed by the European academy of neurology. Eur Stroke J. 2017;2:195-221. https://doi.org/10.1177/2396987317719364
Aguiar de Sousa D, Lucas Neto L. Advances in Cerebral Venous Thrombosis. Stroke. 2024;55(8):2169-2172. https://doi.org/10.1161/STROKEAHA.123.044266